These are not, of course, grounds for condemning epidural anaesthesia. It should not, in Reynold's terms, be "classed with other forms of obstetric intervention as undesirable interference by the medical profession in what would otherwise be a trouble free and satisfying natural event."7 In addition to providing the only really effective form of pain relief during labour,89 an epidural offers a number of positive clinical benefits for both the mother'0" and the baby.'2-'4 Moreover, the backache is not solely a consequence of epidural anaesthesia but is probably due to a combination of muscular relaxation and postural stresses in labour. The problem now is to determine in precise detail the mechanisms that result in backache and to refine the management of epidural anaesthesia in labour.
Objective-To determine the frequency of an abnormal bleeding time in patients with cirrhosis and to relate this to known factors that affect primary haemostasis and to the severity of liver disease.
Design-Prospective clinical and laboratory study in patients admitted for complications or investigations of liver disease.
Setting-Royal Free Hospital hepatobiliary and liver transplantation unit.
Subjects-100 Consecutive inpatients aged with various forms of cirrhosis, including alcoholic, biliary, autoimmune, viral, and cryptogenic. At least 10 days had elapsed since any episodes of bleeding, resolution of sepsis, or alcohol intake. No patient was taking any drug known to affect primary haemostasis.
Main outcome measures-Bleeding time as measured with the Simplate double blade template device. A bleeding time longer than 10 minutes was considered abnormal. Other measures were platelet count, prothrombin time, partial thromboplastin time, packed celi volume, and blood urea, serum bilirubin, and serum albumin concentrations, all measured on each subject at the same time by standard laboratory methods.
Results -A weak but significant correlation existed between the bleeding time and the platelet count (r,=0-483; p<0-001). There were significantly lower platelet counts, longer prothrombin times, and higher blood urea and serum bilirubin concentrations in the 42 patients with bleeding times of 10 4 Harker and Slichter showed that in thrombocytopenia due to decreased platelet production the bleeding time is inversely correlated with platelet counts below 100x 109/l (r=-0 971; p<0001).5 They also found this relation in 11 patients with hypersplenism, but they included only four patients with cirrhosis in their study.
Although severe thrombocytopenia is reportedly unusual in patients with cirrhosis,6`platelet counts below 100x 109/l are common. Standard texts of hepatology and haematology do not discuss the bleeding time or the effect of thrombocytopenia and other factors on primary haemostasis in patients with, chronic liver disease.69 Moreover, only a few studies of haemostatic function in liver disease have included measurements of the bleeding time"'0-2 and no study has examined the relations among bleeding time, platelet count, and liver function. Hence not surprisingly the bleeding time is not routinely measured before percutaneous liver biopsy or other invasive procedures in patients with chronic liver disease.
It is usually considered that a liver biopsy can be performed with very little risk of bleeding if the platelet count is more than 80 x 10/l and the prothrombin time is not prolonged by more than three seconds over the control value (that is, a prothrombin time of 17 seconds or less). " In two large surveys troublesome bleeding after liver biopsy occurred in about 0-06% of patients.'4" When bleeding after liver biopsy was assessed by liver bleeding times measured after laparoscopic liver biopsy there was no correlation with any index of haemostasis,'6 but neither skin bleeding times nor platelet function were examined.
This study aimed at assessing the frequency of abnormal bleeding times in patients with cirrhosis and the relation of this to factors known to affect primary haemostasis and to the severity of liver disease. The platelet count, prothrombin time, partial thromboplastin time, packed cell volume, and blood urea; serum total bilirubin, and serum albumin concentrations were measured on each patient by standard laboratory methods on the same day as the bleeding time. The relation between the platelet count and the bleeding time was examined by Spearman's rank correlation, which was calculated for the whole population and for two subgroups divided according to the platelet count (100x 10'/1 or over, and below 100x 109/1) for comparison with results quoted previously.'
The study population was also examined in relation to normal and abnormal bleeding times. The statistical significance of differences between patients with an abnormal bleeding time (10 minutes or more) and those with a normal bleeding time (less than 10 minutes) for each of the measured variables (platelet count, prothrombin time, partial thromboplastin time, packed cell volume, blood urea concentration, serum total bilirubin concentration, and serum albumin concentration) was tested by the Mann-Whitney U test. Multiple linear regression analysis was used to determine whether any of these variables correlated independently with the bleeding time.
Results
An abnormal bleeding time was found in 42 of our 100 patients. There were no differences in the aetiology of the liver disease between the group with abnormal bleeding times (median 16 5 minutes, range 10-31) and the group with normal bleeding times (median 6-0 minutes, range 2-5-9 5) (table I). There were no differences in mean platelet counts between alcoholic and non-alcoholic groups, except that patients with cirrhosis due to viral infection had significantly lower platelet counts (mean 51 x1 09/l) than patients with alcohol related disease (Mann-Whitney U test, p=0006). Only five patients, however, had a viral aetiology. There were no other significant differences among any of the other aetiological groups. The platelet count showed a weak but significant correlation with the bleeding time (r,=-0 483; p<0 001). A similar correlation with bleeding time also existed in each of the two subgroups divided according to the platelet count (lOOx109/l or over: r,=-0 470, p<0001; below 100x10'/l: r,=-0 385, p=0 005) (figure). Fourteen patients had a prolonged bleeding time (¢c 10 minutes) despite platelet counts greater than 100x 109/l and 23 patients had a normal bleeding time (<10 minutes) despite platelet counts of less than lOOx 109/1.
A platelet count greater than 80x 1 0'/l and a prothrombin time less than 17 seconds (our usual "safe limits" for performing a routine percutaneous liver biopsy) did not predict a normal bleeding time. Of 39 patients fulfilling these criteria, 10 had a bleeding time of 10 minutes or more. They represented 24% of the 42 patients with an abnormal bleeding time. In contrast, of 21 patients with a platelet count of less than 80 x 109/1 and a prothrombin time of greater than 17 seconds, nine patients had normal bleeding times (table II) .
There were significant differences between the group of patients with an abnormal bleeding time and the group with a normal bleeding time with respect to platelet count, prothrombin time, partial thromboplastin time, and blood urea and serum bilirubin concentrations (all p<005), but no significant dit-BMJ VOLUME 301 ferences were observed for packed cell volume or serum albumin concentration (table III) . The factors which had a statistically significant regression coefficient when tested univariately with bleeding time (log prothrombin time, log partial thromboplastin time, log bilirubin concentration, log platelet count, all p<0-01) as well as log blood urea concentration and log packed cell volume (included because of the known associations of uraemia and low packed cell volume with abnormal bleeding time) were included in a multiple linear regression analysis. Only serum bilirubin concentration and platelet count were independently correlated with bleeding time. The 3 coefficients (SD) and p values were: log serum bilirubin concentration 0 190 (0 136), p=0 007; and log platelet count -0410 (0 190), p<0001.
Discussion
This is the largest reported survey of the bleeding time in patients with cirrhosis. Only three studies have measured the bleeding time in patients with cirrhosis. None, however, examined the relations among bleeding time, platelet count, and liver function. Stein and Harker stated that the bleeding times were generally appropriate for the platelet count in 60 patients with cirrhosis,'0 but neither the data nor the statistical correlations were given. Ballard and Marcus included measurements of both the platelet count (range 46-516x 109/l) and bleeding time (range 5-27 minutes) in 24 patients with cirrhosis but did not discuss the poor correlation between the two, which was evident from their data." Hallen and Nilsson studied 20 patients with cirrhosis, 11 of whom had low platelet counts but none a prolonged Duke bleeding time. 12 In our study the bleeding time showed a weak correlation with the platelet count (r,=-0 483; p<0-001). The correlation for platelet counts below lOOx109/l in our 100 patients was weaker still (r,= -0 385; p=0 005), in contrast with the strong correlation (r=-0 971; p<0-001) found by Harker and Slichter in 70 patients with thrombocytopenia due to decreased platelet production.' Using multiple linear regression analysis, we also found that both the platelet count and the serum bilirubin concentration were independently correlated with bleeding time, suggesting that liver function has an important role in determining primary haemostasis in patients with cirrhosis. Abnormal platelet function is well recognised in cirrhosis'820 and is related to the severity of liver disease. It may be due to various mechanisms. Rubin (table I) .
